Brazil · Delayed Price · Currency is BRL Cruzeiro do Sul Educacional Earnings Call Transcripts
Fiscal Year 2026
-
Net income for H1 2025 reached a record BRL 149 million, surpassing all of 2024, with strong revenue and EBITDA growth driven by student base expansion and operational efficiency. Health courses now account for 71% of on-campus revenue, and net debt fell 21% year-over-year.
-
Record free cash generation and net earnings were achieved in Q3 2024, driven by strong student base growth, margin expansion, and operational efficiency. The company remains resilient to regulatory changes and continues to invest in high-value segments and technology.
-
Record earnings and revenue growth in 2024 were driven by a 12% expansion in the student base, operational efficiency, and strategic investments. Free cash flow and dividends reached historic highs, while leverage decreased and digital transformation accelerated.
-
Net revenue rose 13% in H1 2024, driven by student base growth and higher average ticket. Adjusted EBITDA and net earnings increased, with strong free cash generation and expanded medical school capacity via FAPI acquisition. Digital transformation and operational efficiencies continue to support growth.
-
Record net profit and strong revenue growth in 2025 were driven by student base expansion, operational efficiency, and innovation. Strategic investments in technology and adaptation to new regulations position the company for continued growth and high retention rates.
-
Q3 2025 saw strong financial and operational performance, with net income up 82% and cash flow to shareholders up 35% year-over-year. Growth was driven by healthcare and digital segments, efficiency gains, and a disciplined capital allocation approach.
-
Record Q1 2025 results with adjusted net earnings up 98% and net revenue rising 10% year-over-year, driven by student base growth, strong health segment performance, and operational efficiencies. Digital learning faced competitive pressure, but aggressive marketing and pricing strategies yielded significant intake gains.